Overweight

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA safety_alert · 2009-12-18
European Medicines Agency updates on ongoing safety review of sibutramine: Weight-loss medicine assessed over cardiovascular concerns
The EMA provides updates on ongoing safety review of sibutramine, a weight-loss medicine, focusing on cardiovascular concerns.